Noted cataract surgeon Dr. David Chang describes
recent changes in the management of intraoperative
floppy-iris syndrome (IFIS) in an interview with
refractive editor Dr. David Goldman. Dr. Chang
summarizes the results of a new survey of ASCRS
members on current practices in IFIS and describes his
own strategies for the assessment of IFIS risk. He
then offers a few surgical pearls regarding the use of
pharmacologic agents, instrumentation and OVDs in
treating these patients.